den Brok MH - Search Results

1

Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis.

Morgan ME, Koelink PJ, Zheng B, den Brok MH, van de Kant HJ, Verspaget HW, Folkerts G, Adema GJ, Kraneveld AD. Morgan ME, et al. Among authors: den brok mh. Mucosal Immunol. 2014 Sep;7(5):1266-77. doi: 10.1038/mi.2014.16. Epub 2014 Mar 26. Mucosal Immunol. 2014. PMID: 24670426 Free PMC article.

2

Generation of αCD11b-CpG antibody conjugates for the targeted stimulation of myeloid cells.

Balneger N, Kroesen M, Lindau D, Wassink M, Boon L, den Brok MH, Büll C, Adema GJ. Balneger N, et al. Among authors: den brok mh. J Control Release. 2021 Apr 10;332:148-159. doi: 10.1016/j.jconrel.2021.02.017. Epub 2021 Feb 18. J Control Release. 2021. PMID: 33609622

3

In vivo colocalization of antigen and CpG [corrected] within dendritic cells is associated with the efficacy of cancer immunotherapy.

Nierkens S, den Brok MH, Sutmuller RP, Grauer OM, Bennink E, Morgan ME, Figdor CG, Ruers TJ, Adema GJ. Nierkens S, et al. Among authors: den brok mh. Cancer Res. 2008 Jul 1;68(13):5390-6. doi: 10.1158/0008-5472.CAN-07-6023. Cancer Res. 2008. PMID: 18593941

4

DC-STAMP knock-down deregulates cytokine production and T-cell stimulatory capacity of LPS-matured dendritic cells.

Sanecka A, Ansems M, Prosser AC, Danielski K, Warner K, den Brok MH, Jansen BJ, Eleveld-Trancikova D, Adema GJ. Sanecka A, et al. Among authors: den brok mh. BMC Immunol. 2011 Oct 6;12:57. doi: 10.1186/1471-2172-12-57. BMC Immunol. 2011. PMID: 21978263 Free PMC article.

5

A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.

Kroesen M, Nierkens S, Ansems M, Wassink M, Orentas RJ, Boon L, den Brok MH, Hoogerbrugge PM, Adema GJ. Kroesen M, et al. Among authors: den brok mh. Int J Cancer. 2014 Mar 15;134(6):1335-45. doi: 10.1002/ijc.28463. Epub 2013 Sep 14. Int J Cancer. 2014. PMID: 24038106 Free article.

6

Sweet escape: sialic acids in tumor immune evasion.

Büll C, den Brok MH, Adema GJ. Büll C, et al. Among authors: den brok mh. Biochim Biophys Acta. 2014 Aug;1846(1):238-46. doi: 10.1016/j.bbcan.2014.07.005. Epub 2014 Jul 12. Biochim Biophys Acta. 2014. PMID: 25026312 Review.

7

Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation.

Büll C, Collado-Camps E, Kers-Rebel ED, Heise T, Søndergaard JN, den Brok MH, Schulte BM, Boltje TJ, Adema GJ. Büll C, et al. Among authors: den brok mh. Immunol Cell Biol. 2017 Apr;95(4):408-415. doi: 10.1038/icb.2016.105. Epub 2016 Nov 22. Immunol Cell Biol. 2017. PMID: 27874015

8

Toll-like receptor 2 controls expansion and function of regulatory T cells.

Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ, Joosten LA, Akira S, Netea MG, Adema GJ. Sutmuller RP, et al. Among authors: den brok mh. J Clin Invest. 2006 Feb;116(2):485-94. doi: 10.1172/JCI25439. Epub 2006 Jan 19. J Clin Invest. 2006. PMID: 16424940 Free PMC article.

9

Sialic acids sweeten a tumor's life.

Büll C, Stoel MA, den Brok MH, Adema GJ. Büll C, et al. Among authors: den brok mh. Cancer Res. 2014 Jun 15;74(12):3199-204. doi: 10.1158/0008-5472.CAN-14-0728. Epub 2014 May 15. Cancer Res. 2014. PMID: 24830719 Review.

10

Lipid Droplets as Immune Modulators in Myeloid Cells.

den Brok MH, Raaijmakers TK, Collado-Camps E, Adema GJ. den Brok MH, et al. Trends Immunol. 2018 May;39(5):380-392. doi: 10.1016/j.it.2018.01.012. Epub 2018 Feb 22. Trends Immunol. 2018. PMID: 29478771 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page